Showing results (41-50 of 336) with videos related to

Sort By:
Pageof 34
Nature Clinical Practice. Rheumatology|June 1, 2007
Emerging targets of biologic therapies for rheumatoid arthritisIngo H Tarner, Ulf Müller-Ladner, Steffen Gay
The Journal of Allergy and Clinical Immunology|August 11, 2020
Mutual regulation of metabolic processes and proinflammatory NF-κB signalingMichael Kracht, Ulf Müller-Ladner, M Lienhard Schmitz
Current Pharmaceutical Biotechnology|January 4, 2019
The Role of Extracellular Nucleic Acids in Rheumatoid ArthritisElena Neumann, Rebecca Hasseli, Uwe Lange, et al.
Methods in Molecular Medicine|October 24, 2007
Genotyping of synovial fibroblasts: cDNA array in combination with RAP-PCR in arthritisElena Neumann, Martin Judex, Steffen Gay, et al.
Autoimmunity|June 14, 2006
Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomideUwe Lange, Manfred Piegsa, Ulf Müller-Ladner, et al.
Clinical Transplantation|September 24, 2017
Weekly oral bisphosphonates over 2 years prevent bone loss in cardiac transplant patientsUwe Lange, Katharina Classen, Ulf Müller-Ladner, et al.
Trends in Biotechnology|May 26, 2004
Targeted gene therapy: frontiers in the development of 'smart drugs'Ingo H Tarner, Ulf Müller-Ladner, C Garrison Fathman
Microvascular Research|June 9, 2026
Serial CO₂ hand baths are associated with improved microvascular parameters and Raynaud-related symptoms in systemic sclerosis: A controlled feasibility studyNils Schulz, Ulf Müller-Ladner, Uwe Lange, et al.
Methods in Molecular Medicine|August 10, 2004
Laser-mediated microdissection as a tool for molecular analysis in arthritisMartin Judex, Elena Neumann, Steffan Gay, et al.
Expert Review of Clinical Immunology|September 24, 2015
Scientific rationale behind the development and approval of biosimilar infliximab (CT-P13) in EuropeUlf Müller-Ladner, SeungSuh Hong, Choongseob Oh, et al.
Pageof 34